Select Page

BioIQ’s Chief Medical Officer, Josh Sclar, MD, MPH, recently partnered with the Population Health Alliance to discuss how technology, convenience and personalization can transform colorectal cancer screening rates and save more lives.

Colorectal cancer is currently the second leading cause of death from cancer in the United States with an estimated 135,430 cases in 2017. Although new cases and the number of deaths from colorectal cancer have started to decline over the years, new cases in adults under the age of 50 have been slowly increasing since 1998.

“It’s 2018, which means the moment of truth has arrived for the National Colorectal Cancer Roundtable’s “80% by 2018” initiative for colorectal cancer screening,” said Sclar. “Needless to say, we’re not measuring up. And with the American Cancer Society lowering their recommendation of age that screening should start — from 50 to 45 — even more unscreened people may need this critical test.”

Access the free, on-demand webinar here.

To learn how your organization can implement a convenient, effective CRC screening program, contact BioIQ at (888) 818-1594 or sales@bioiq.com.

 

Share This